This is an online survey study that was conducted in Saudi Arabia between December 2024 and January 2025 to examine community awareness and attitudes regarding the use of GLP-1 agonists as a treatment for obesity in Saudi Arabia. The gene discussed is GCG; the disease is obesity disorder.